Fda Warns Seniors To Avoid This Vaccine After Deadly Complications

Older adults are being warned against receiving nan chikungunya vaccine earlier traveling.

The Ixchiq vaccination, developed by Valneva to forestall nan mosquito-borne chikungunya virus, was approved by nan Food and Drug Administration (FDA) successful November 2023 arsenic nan first of its kind.

The support applies to anyone aged 18 and older who has a consequence of being exposed to nan virus.

FIRST VACCINE FOR CHIKUNGUNYA VIRUS, AN ‘EMERGING GLOBAL HEALTH THREAT,’ GETS FDA APPROVAL

But nan FDA and nan Centers for Disease Control and Prevention (CDC) released a information announcement connected May 9 recommending that adults complete 60 years old region usage of nan vaccine owed to fatal complications.

"FDA and CDC will proceed nan information of post-marketing information reports for Ixchiq," nan merchandise reads. 

Older adults are being warned against receiving nan chikungunya vaccine earlier traveling. (iStock)

"While nan information of Ixchiq for usage successful individuals 60 years of property and older is being further assessed, FDA and CDC are recommending a region successful usage of nan vaccine successful this property group. FDA and CDC will update nan nationalist erstwhile nan agencies complete their information of this information issue."

The advisory follows reports of "serious adverse events," including neurologic and cardiac events successful group who received nan vaccine.

CLICK HERE TO GET THE FOX NEWS APP    

Two of 17 events resulted successful decease from terrible complications. One decease was caused by encephalitis, aliases inflammation successful nan brain, nan alert stated.

Those who knowledgeable adverse effects of nan vaccine were reported to beryllium betwixt nan ages of 62 and 89.

A diligent infected pinch chikungunya looks retired from mosquito netting astatine nan Clinicas Hospital successful San Lorenzo, Paraguay, successful March 2023. The FDA warned that Ixchiq, which contains a live, weakened type of nan virus, whitethorn origin akin symptoms to chikungunya. (AP Photo/Jorge Saenz)

The FDA warned that Ixchiq, which contains a live, weakened type of chikungunya, whitethorn origin symptoms akin to the virus.

Typical symptoms of chikungunya see fever, terrible associated pain, headache, musculus symptom and a rash, according to nan CDC. 

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Most group retrieve wrong a week, but immoderate whitethorn acquisition "severe and disabling" associated symptom for weeks aliases months. 

Chikungunya is dispersed by nan wound of infected mosquitoes. (iStock)

"This microorganism is successful a akin class arsenic dengue aliases Zika and is carried by nan same mosquitoes," Fox News elder aesculapian expert Dr. Marc Siegel antecedently told Fox News Digital.

At nan clip of nan vaccine's approval, nan FDA described chikungunya arsenic an "emerging world health threat," pinch astatine slightest 5 cardinal cases reported complete nan past 15 years. 

For much Health articles, visit www.foxnews.com/health

The FDA plans to behaviour an "updated benefit-risk assessment" for Ixchiq usage successful those complete 60 years of age, according to nan notice.

Fox News Digital's Melissa Rudy contributed to this report.